Adequacy of haemodialysis and associated factors among patients with end-stage kidney disease in Tanzania

被引:2
|
作者
Bakari, Abilah I. [1 ]
Yahaya, James J. [2 ]
Matobogolo, Boaz M. [1 ]
Abraham, Zephania S. [3 ]
Mpondo, Bonaventura [1 ]
机构
[1] Univ Dodoma, Sch Med & Dent, Dept Internal Med, Dodoma, Tanzania
[2] Soroti Univ, Sch Hlth Sci, Dept Pathol, POB 211, Soroti, Uganda
[3] Univ Dodoma, Sch Med & Dent, Dept Surg, Dodoma, Tanzania
来源
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES | 2024年 / 19卷 / 02期
关键词
Adequacy; Chronic kidney disease; Clinical outcome; Factors associated; Haemodialysis; TWICE-WEEKLY HEMODIALYSIS; DIALYSIS INITIATION; MORTALITY; PREVALENCE; CARE;
D O I
10.1016/j.jtumed.2023.12.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adequate haemodialysis helps maintain normal renal function by removing toxins and other waste products in patients with end-stage kidney disease. This study was aimed at determining the prevalence and predictors of adequacy of haemodialysis and outcomes in patients with end-stage kidney disease. Methods: This longitudinal analytical hospital-based study was conducted at two dialysis centres in Dodoma city, Tanzania, between February and July of 2020. Adequacy of haemodialysis was measured with single-pool (sp) Kt/V and urea reduction rate (URR) formulae. Binary logistic regression and multivariable analysis were used to assess the independent predictors of adequacy of haemodialysis. Results: The analysis included 100 patients with a mean age of 50.6 +/- 15.0 years. The prevalence of adequacy of haemodialysis according to URR and sp-Kt/V was 72 % and 75 %, respectively. Having <12 months since dialysis initiation (AOR = 7.3, 95 % CI = 0.11-0.90, p = 0.032), fewer than three dialysis sessions per week (AOR = 6.9, 95 % CI = 1.52-31.49, p = 0.013) and severe anaemia (AOR = 2.2, 95 % CI = 0.26-0.93, p = 0.033) were predictors of inadequate haemodialysis, according to the URR formula. Having fewer than three dialysis sessions per week was significantly associated with inadequate haemodialysis (AOR = 5.6, 95 % CI = 1.47-19.66, p = 0.011), according to the sp-Kt/V formula. The mortality rate was 11.2 %, and cardiovascular disease and uremic syndrome were responsible for most deaths. Conclusion: This study indicated a high percentage of adequacy of haemodialysis among patients with endstage kidney disease. Having fewer than three dialysis sessions per week, late initiation of dialysis after diagnosis of end-stage kidney disease and severe anaemia were predictors of inadequate haemodialysis among patients.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [31] THE EFFECTS OF PHYSICAL EXERCISE IN CHRONIC END-STAGE KIDNEY FAILURE PATIENTS ON HAEMODIALYSIS
    Zagalaz Sanchez, Ma Luisa
    Pena Amaro, Pilar
    Martinez Vidal, Aurora
    Mateos Padorno, Covadonga
    Martinez Patino, Maria Jose
    JOURNAL OF HUMAN SPORT AND EXERCISE, 2010, 5 (01): : 101 - 113
  • [32] Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis
    Zhang, Quanchao
    Ma, Yingying
    Lin, Faying
    Zhao, Jinghong
    Xiong, Jiachuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (02) : 363 - 370
  • [33] Breath analysis in patients with end-stage renal disease: effect of haemodialysis
    Rolla, G.
    Bruno, M.
    Bommarito, L.
    Heffler, E.
    Ferrero, N.
    Petrarulo, M.
    Bagnis, C.
    Bugiani, M.
    Guida, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (10) : 728 - 733
  • [34] Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality
    Whaley-Connell, Adam
    Shlipak, Michael G.
    Inker, Lesley A.
    Tamura, Manjula Kurella
    Bomback, Andrew S.
    Saab, Georges
    Szpunar, Susanna M.
    McFarlane, Samy I.
    Li, Suying
    Chen, Shu-Cheng
    Norris, Keith
    Bakris, George L.
    McCullough, Peter A.
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (07) : 661 - 669
  • [35] Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis
    Khadzhynov, Dmytro
    Slowinski, Torsten
    Lieker, Ina
    Neumayer, Hans-Hellmut
    Albrecht, Diego
    Streefkerk, Henk Johan
    Rebello, Sam
    Peters, Harm
    CLINICAL PHARMACOKINETICS, 2012, 51 (10) : 661 - 669
  • [36] Survival Factors in Patients With End-stage Renal Disease in Mazandaran Province, Iran
    Shabankhani, Bizhan
    Kazemnejad, Anoushirvan
    Zaeri, Farid
    Espahbodi, Fatemeh
    Ahmadi, Mahmoud Haji
    Mirkazemi, Roksana
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (02) : 79 - 84
  • [37] Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease
    Omran, Jad
    Al-Dadah, Ashraf
    Dellsperger, Kevin C.
    CARDIORENAL MEDICINE, 2013, 3 (03) : 165 - 177
  • [38] Epicardial adipose tissue in patients with end-stage renal disease on haemodialysis
    Graham-Brown, Mathew P. M.
    McCann, Gerry P.
    Burton, James O.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (06) : 517 - 524
  • [39] Ischemic Heart Disease in Patients with End-Stage Kidney Disease
    Tanaka, Yuri
    Joki, Nobuhiko
    Hase, Hiroki
    BLOOD PURIFICATION, 2015, 40 (04) : 332 - 336
  • [40] Management of Elderly Patients With End-Stage Kidney Disease
    Dimkovic, Nada
    Oreopoulos, Dimitrios
    SEMINARS IN NEPHROLOGY, 2009, 29 (06) : 643 - 649